Arrowstreet Capital’s Viemed Healthcare VMD Stock Holding History

Arrowstreet Capital’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.96M	Buy	786,269 +75,083	+11%	+$743K	﹤0.01%	1113
2026 Q1	$6.55M	Buy	711,186 +358,863	+102%	+$2.99M	﹤0.01%	1073
2025 Q4	$2.62M	Hold	352,323	–	–	﹤0.01%	1329
2025 Q3	$2.39M	Buy	352,323 +118,589	+51%	+$803K	﹤0.01%	1409
2025 Q2	$1.62M	Hold	233,734	–	–	﹤0.01%	1503
2025 Q1	$1.7M	Buy	233,734 +40,638	+21%	+$319K	﹤0.01%	1344
2024 Q4	$1.55M	Buy	+193,096	New	+$1.68M	﹤0.01%	1349
2024 Q1	–	Sell	-126,066	Closed	-$990K	–	1783
2023 Q4	$990K	Sell	126,066 -81,741	-39%	-$593K	﹤0.01%	1103
2023 Q3	$1.4M	Sell	207,807 -63,440	-23%	-$520K	﹤0.01%	919
2023 Q2	$2.65M	Buy	+271,247	New	+$2.75M	﹤0.01%	760
2020 Q4	–	Sell	-10,400	Closed	-$90K	–	2558
2020 Q3	$90K	Buy	+10,400	New	+$105K	﹤0.01%	2260
2020 Q1	–	Sell	-27,500	Closed	-$172K	–	2138
2019 Q4	$172K	Buy	+27,500	New	+$191K	﹤0.01%	1630

Other funds holding VMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital's VMD Position: Q2 2026 in Review

Arrowstreet Capital increased its Viemed Healthcare (VMD) stake by 11% in Q2 2026, buying an estimated $743K and bringing the position to 786,269 shares worth $8.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1113.

Arrowstreet Capital first reported a position in VMD in Q4 2019 and has held it in 12 quarters since. 137 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

Arrowstreet Capital held 786,269 shares of Viemed Healthcare worth $8.96M as of Q2 2026.
Arrowstreet Capital bought 75,083 Viemed Healthcare shares in Q2 2026, an estimated $743K.
Viemed Healthcare made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1113 holding.
Arrowstreet Capital first reported a position in Viemed Healthcare in Q4 2019 and has held it in 12 quarters since.
137 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.